Barbara S. Bock-Hennig

755 citations
20 papers · 640 indexed · h-index 15
Topics
Pharmacogenetics and Drug Metabolism (16 papers)Carcinogens and Genotoxicity Assessment (9 papers)Drug Transport and Resistance Mechanisms (7 papers)
Partner nations
GermanySwedenEgypt

In The Last Decade

Barbara S. Bock-Hennig

20 papers receiving 624 citations

Peers

Barbara S. Bock-Hennig
Comparison fields: 5 of 77
  • Pharmacology 332
  • Molecular Biology 239
  • Oncology 196
  • Cancer Research 147
  • Health, Toxicology and Mutagenesis 100
Replace Stephen Murray with:
Stephen Murray United Kingdom
Bok-Ryang Kim South Korea
Kim J. Rich United Kingdom
Joyce Massengill United States
William J. Bement United States
Marià Pitarque Spain
R.M.E. Vos Netherlands
J.A. Beamand United Kingdom
Jun-Yan Hong United States
J. A. Miller United States
Barbara S. Bock-Hennig relative to Stephen Murray United Kingdom Stephen Murray's profile →
Citations per field
00.5×3.3×
Stephen Murray · 1×
Citations per year

Countries citing papers authored by Barbara S. Bock-Hennig

Since Specialization
Citations

This map shows the geographic impact of Barbara S. Bock-Hennig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara S. Bock-Hennig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara S. Bock-Hennig more than expected).

Fields of papers citing papers by Barbara S. Bock-Hennig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara S. Bock-Hennig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara S. Bock-Hennig. The network helps show where Barbara S. Bock-Hennig may publish in the future.

Co-authorship network of co-authors of Barbara S. Bock-Hennig

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara S. Bock-Hennig. A scholar is included among the top collaborators of Barbara S. Bock-Hennig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara S. Bock-Hennig. Barbara S. Bock-Hennig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 33
2 26
3 20
4 19
5 17
6 12
7 49
8 100
9 35
10 24
11 48
12 63
13 43
14 5
15 62
16 6
17 37
18 8
19 3
20 30

About Barbara S. Bock-Hennig

Barbara S. Bock-Hennig is a scholar working on Pharmacology, Cancer Research and Oncology, having authored 20 papers that have together received 640 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Pharmacology (332 citations), Cancer Research (147 citations) and Health, Toxicology and Mutagenesis (100 citations). Barbara S. Bock-Hennig has collaborated with scholars based in Germany, Sweden and Egypt. Frequent co-authors include Karl Walter Bock, Peter Münzel, Werner Lilienblum, Hans‐Peter Lipp, Harald Gschaidmeier, Christoph Köhle, Dieter Schrenk, Osama A. Badary, D. Ullrich and Lorenz Poellinger. Their work appears in journals such as Pharmacology & Therapeutics, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026